What is Positron?
Positron is a leading provider of advanced molecular imaging technology, specializing in cardiac PET and PET-CT solutions. The company develops high-precision imaging systems, such as the NeuSight PET-CT, designed to enhance cardiac diagnostics by improving scan accuracy, reducing scan times, and optimizing patient care. Positron is committed to advancing the adoption of PET imaging in cardiology by delivering innovative imaging solutions, clinical support, and superior value to healthcare providers.
How much funding has Positron raised?
Positron has raised a total of $305.1M across 3 funding rounds:
Seed
$23.5M
Series A
$51.6M
Series B
$230M
Seed (2025): $23.5M with participation from Flume Ventures, Atreides Management, and Valor Equity Partners
Series A (2025): $51.6M led by 1517 Fund I, Atreides Management, Valor Equity Partners, DFJ Growth, Unless, and Flume Ventures
Series B (2026): $230M supported by Flume Ventures, Valor Equity Partners, Unless, Jump Trading, and DFJ Growth
Key Investors in Positron
Flume Ventures
Flume Ventures is a network of seasoned operators and founders dedicated to partnering with visionary entrepreneurs to scale bold ideas, providing guidance and mentorship.
Atreides Management
Atreides Management focuses on long-term investment for companies in the technology and consumer businesses, operating in both public and private markets.
Valor Equity Partners
Valor Equity Partners provides financial services, specializing in investment activities for businesses, and was established in 2001.
What's next for Positron?
With its recent major strategic investment and a history of significant capital raises, Positron is well-positioned for accelerated growth and market expansion. The company's focus on enhancing cardiac diagnostics through innovative PET and PET-CT solutions indicates a strategic direction towards solidifying its leadership in the medical imaging sector. Future developments are likely to involve further refinement of its imaging systems, broader clinical integration, and potentially exploring new applications for its technology, leveraging this latest backing to drive innovation and patient care improvements.
See full Positron company page
